
AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.

AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.
Focus: AI-enabled drug discovery and repurposing for rare diseases
Headquarters: Cambridge, United Kingdom
Founded: 2014
Employees (approx.): 125
Total disclosed funding: USD 114,900,000
Recent round: Series C $47M (Aug 2024)
Rare disease therapeutics discovery and development
2014
Biotechnology / Drug discovery
USD 56,000,000
USD 47,000,000